HR-Positive Metastatic Breast Cancer — An Interview with Dr Seth Wander on Biomarker Assessment and Related Treatment Decision-Making (Companion Faculty Lecture)

Featuring a slide presentation and related discussion from Dr Seth Wander, including the following topics:

Biological impact of clinically relevant biomarkers (eg, ESR1 mutations, PIK3CA/AKT1/PTEN alterations) (0:00)

Methodologies for biomarker assessment in clinical practice: Tissue versus liquid biopsy (5:21)

Methodologies for biomarker assessment in clinical practice: Novel platforms (13:56)

Appropriate timing for assessment of ESR1 and PI3K pathway alterations (17:34)

Evolving guidelines for routine biomarker evaluation (21:37)

Implications of precision oncology clinical trials for future…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.